Incidental detection by [11C]choline PET/CT of meningiomas in prostate cancer patients

Quarterly Journal of Nuclear Medicine and Molecular Imaging

Volumn 53, Issue 4, 2009, Pages 417-421

  Fallanca, F ^a   Giovacchini, G ^b   Picchio, M ^a   Bettinardi, V ^a   Messa, C ^b,c,d   Fazio, F ^a,b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c SAN GERARDO HOSPITAL   (Italy)

^d INSTITUTE OF MOLECULAR BIOIMAGING AND PHYSIOLOGY   (Italy)

Author keywords

Choline; Computed tomography; Gonadotropin releasing hormone, agonists and inhibitors; Meningioma; Prostatic neoplasms; Tomography, emission computed

Indexed keywords

BICALUTAMIDE; CHOLINE C 11; GONADORELIN; LEUPRORELIN; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONFERENCE PAPER; CONTROLLED STUDY; FOLLOW UP; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; NEURORADIOLOGY; PROSTATE CANCER; ARTICLE; BRAIN TUMOR; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; INCIDENTAL FINDING; METHODOLOGY; MIDDLE AGED; MULTIPLE CANCER; POSITRON EMISSION TOMOGRAPHY; PROSTATE TUMOR; RETROSPECTIVE STUDY;

AGED; BRAIN NEOPLASMS; FEMALE; HUMANS; INCIDENTAL FINDINGS; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; POSITRON-EMISSION TOMOGRAPHY; PROSTATIC NEOPLASMS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 74949133651     PISSN: 18244785     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (17)

1. DeAngelis LM. Brain tumors. N Engl J Med 2001;344:114-23.
2. Lee KL, Terris MK. Luteinizing hormone-releasing hormone agonists and meningioma: a treatment dilemma. Urology 2003;62:351.
3. Davis C. Meningiomas and sex hormones. Eur J Cancer 1990;26:859-60.
4. 18F]fluorodeoxyglucose- positron emission tomography. J Urol 2003;169:1337-40.
5. Krause BJ, Souvatzoglou M, Tuncel M, Herrmann K, Buck AK, Praus C et al. The detection rate of [(11)C]Choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer. Eur J Nucl Med Mol Imaging 2008;35:18-23.
6. 18F]FDG-PET. Q J Nucl Med 2004;48:12.
7. Ohtani T, Kurihara H, Ishiuchi S, Saito N, Oriuchi N, Inoue T et al. Brain tumour imaging with carbon-11 choline: comparison with FDG PET and gadolinium-enhanced MR imaging. Eur J Nucl Med 2001;28:1664-70.
8. Giovacchini G, Picchio M, Coradeschi E, Vassenna E, Landoni C, Gianolli L et al. Predictive factors of [(11)C]Choline PET/CT uptake in patients with biochemical failure. J Nucl Med 2008;49:19P.
9. 11C]choline, a positron-emitting tracer for tumor imaging. Appl Radiat Isot 1999;50:531-3.
10. De Verdelhan O, Haegelen C, Carsin-Nicol B, Riffaud L, Amlashi SF, Brassier G et al. MR imaging features of spinal schwannomas and meningiomas. J Neuroradiol 2005;32:42-9.
11. Partin AW, Pearson JD, Landis PK, Carter HB, Pound CR, Clemens JQ et al. Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases. Urology 1994;43:649-59.
12. Buhl R, Nabavi A, Wolff S, Hugo HH, Alfke K, Jansen O et al. MR spectroscopy in patients with intracranial meningiomas. Neurol Res 2007;29:43-6.
13. Shino A, Nakasu S, Matsuda M, Handa J, Morikawa S, Inubushi T. Noninvasive evaluation of the malignant potential of intracranial meningiomas performed using proton magnetic resonance spectroscopy. J Neurosurg 1999;91:928-34.
14. Bhakoo KK, Williams SR, Florian CL, Land H, Noble MD. Immortalization and transformation are associated with specific alterations in choline metabolism. Cancer Res 1996;56:4630-5.
15. 11C]choline. J Nucl Med 1997;38:842-7.
16. Durmaz R, Deliorman S, Isiksoy S, Uyar R, Tel E. Luteinizing hormone releasing hormone increases proliferation of meningioma cells in vitro. Arch Physiol Biochem 1999;107:286-91.
17. Olson JJ, Beck DW, Schlechte JA, Loh PM. Effect of the antiprogesterone RU-38486 on meningioma implanted into nude mice. J Neurosurg 1987;66:584-7.